Chapter

Imaging with iodine-123-labelled radiopharmaceuticals

Nikant Sabharwal, Chee Yee Loong and Andrew Kelion

in Nuclear Cardiology

Published on behalf of Oxford University Press

Published in print March 2008 | ISBN: 9780199206445
Published online October 2011 | e-ISBN: 9780191725845 | DOI: http://dx.doi.org/10.1093/med/9780199206445.003.0011

Series: Oxford Specialist Handbooks

Imaging with iodine-123-labelled radiopharmaceuticals

More Like This

Show all results sharing these subjects:

  • Nuclear Medicine
  • Cardiovascular Medicine

GO

Show Summary Details

Preview

123I-labelled radiopharmaceuticals 206

123I-meta-iodo-benzyl-guanidine (123I-MIBG) 208

β‎-methyl-p-[123I]iodo-phenyl-pentadecanoic acid (123I-BMIPP) 210

Nuclear cardiology techniques offer the potential to image aspects of myocardial physiology and metabolism which are not accessible to other imaging modalities. Positron emission tomography (PET) has been extensively used in this area, but for single photon emission computed tomography (SPECT) imaging the range of radiopharmaceuticals available is limited. Two radiopharmaceuticals labelled with iodine-123 (...

Chapter.  1005 words.  Illustrated.

Subjects: Nuclear Medicine ; Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.